SKI Market

A+| A| A-|

Indian Indices

Sensex

76,704.13 633.29
( 0.83%)

Global Indices

Nasdaq

46,241.86 -772.41
(-1.64%)

Dow Jones

6,644.85 -92.24
(-1.37%)

Hang Seng

55,100.12 1,399.73
(2.61%)

Nikkei 225

10,289.25 -114.35
(-1.10%)

Forex

USD-INR

92.33 0.01
(0.01%)

EUR-INR

105.92 0.52
(0.49%)

GBP-INR

122.63 0.58
(0.47%)

JPY-INR

0.58 0.00
(0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

22.36

102442.75

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.26

Back

cipla ltd

Cipla consolidated net profit declines 56.97% in the December 2025 quarter

Jan 23,2026

Net profit of Cipla declined 56.97% to Rs 675.80 crore in the quarter ended December 2025 as against Rs 1570.51 crore during the previous quarter ended December 2024. Sales rose 0.02% to Rs 6962.97 crore in the quarter ended December 2025 as against Rs 6961.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	6962.97	6961.60	0
OPM %	18.02	28.57	-
PBDT	1447.37	2195.89	-34
PBT	1169.02	1916.09	-39
NP	675.80	1570.51	-57

76,704.13 633.29 ( 0.83%)

46,241.86 -772.41 (-1.64%)

6,644.85 -92.24 (-1.37%)

55,100.12 1,399.73 (2.61%)

10,289.25 -114.35 (-1.10%)

92.33 0.01 (0.01%)

105.92 0.52 (0.49%)

122.63 0.58 (0.47%)

0.58 0.00 (0.31%)